Kane Biotech's total assets for Q4 2025 were C$2.73M, a decrease of -0.24% from the previous quarter. TSE:KNE total liabilities were C$3.48M for the fiscal quarter, a -1.51% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.